@sammeciar to be fair, I was already down 94% on Invitae, so a rise of 80% wouldn’t have even gotten close to getting me back to even— but it still hurts to see!

I think this is an example of what @joryko was talking about when he said he had “No sell FOMO”

I.e. the fear of missing out on a great turn around story.

@tomato has also pointed out that once a stock is down so much that it’s an insignificant part of your portfolio, you don’t really get anything by selling it. Might as well write it off in your mind and see if they can make a comeback.

But the counter to that point is that ‘hey it’s still dead money, even if it’s only a little, might as well redeploy” — which is what I fell for here.

@nathanworden Very true, it is tricky. I can find 5-10 “broken” stocks in my portfolio and think - - if I sold them all, I could have one full position in something new I like. 😂

I’m not lucky/smart enough to correctly time both the selling of a current holding and the buying of a new stock, so I’ll just hold and avoid the selling FOMO.

@sammeciar @joryko I've owned $NVTA since October 2020 and today's rise in that stock was by far the biggest one-day percentage gain I've ever had on a stock in my portfolio. Quite possibly the biggest one-day percentage gain I'll ever have in my entire investing career! The problem? The position had dwindled to less than a quarter percent of my portfolio...

So all I have is an amusing good story and a cool screenshot. I chock it up to the vast bucket of experience of being a long-term investor. It would certainly have been a mistake for me to add to this position at its recent lows. There were far too many outstanding questions about this company, and I think you were smart to sell, @nathanworden! There are much easier and better ways to make money out there (anybody checked $TTD today? :))

@wall_street_deebo There are defiantly some companies that are having a very good day 😆🙃

@growthinvesting Yes, so the thesis was that Invitae was going to be able to offer clinical grade genetics testing at a massive scale— and that the genetic data that could be used for treating and curing diseases. Scale was necessary to get useful data, so the company was hemorrhaging money to try and reach that scale. But then the macro environment turned and their runway got cut short. They continually diluted investors and there was no end in sight for that. I sold when the CEO, Sean George stepped down, marking the failure of their strategy and the beginning of a completely new one where they would need to charge much, much more for their genetic tests.

Basically, I had to admit to myself that the business model just isn't there right now, and that management doesn't have a clear plan for making it work either.

They're up big today because of solid Q2 revenue growth with a better-than-expected adjusted loss. They maintained their full-year revenue guidance and are saying they expect a return to stronger growth. This looked like it caused a lot of short sellers to cover their positions, and we got a bit of a squeeze today.

@hedgevision They are undoubtably hard. I'm definitely taking on more risk by choosing to invest in some of them.

@wjared I definitely need a bright side right now!

@stockopine I do find it somewhat morbidly amusing that I was so capable of staunchly holding on the way down, but only once we reached the bottom I sold.

@nathanworden man a $100 investment down to $6, then back up to $10.80. Perfect example of how losses require much bigger gains to get back to even.

@wall_street_deebo so true.

@nathanworden given that it was so insignificant to your portfolio you could just leave it there and forget about it. In any case it would require a 1667% rather than 80% to break even 😮

@stockopine It ended the day up 278% 😭 😭 😭

@nathanworden 😮😮

@rpinvestments Chalk it up to another battle scar 🤼

@sazu this is pretty much exactly what just happened to me! 🥲

@sazu this feels personal

@sazu thanks I appreciate it— looking forward to those days :)

@nathanworden they will come!! (Talking to myself partially here as well lol)

@nes $TTD fell so far so fast. But the rebound has been quick as well.

@nathanworden it’s the hot sauce On motley fool their will be another dip in sure

@dbudd Man... "maximum pain" is a real thing.

@dabincicode71 pshhh 8%? Is this a gain for ants?

@nathanworden Haha, yeah.

@jensen the visual is astounding. I much prefer it in the calls I got right— but nonetheless mesmerizing.

@investor_from_nepal thank you, I’ll carry on 🥹

@irish that was a close one!

@rihardjarc gotta smile or you’ll cry 🥹

But yes, positivity and keeping a good artifice helps take things in stride :)

@nathanworden 100% always better to smile than cry :D

@fatbaby ya really do 🥲

@stock.owl 😆🥲 It is I! Sir Jimmathy Cramer!

@dividenddollars A+ way to put it 🥲

@investmenttalk 😝

@bang happens! Part of the ups and downs of investing!